Background
==========

γ-cystathionase (CSE) is a rate-limiting enzyme of the trans-sulfuration pathway which converts methionine and cystathionine into cysteine and H~2~S. T cells are deficient in CSE and cysteine import and therefore are metabolically dependent on accessory cells for cysteine supply.

Methods and results
===================

In the current study, we demonstrated that pharmacological blockade of CSE with the irreversible inhibitor propargylglycine (PPG) delayed heart allograft rejection (median survival of 26.5 days instead of 9 in controls) and abrogated type IV hypersensitivity to keyhole limpet haemocyanin (Th-1 response), but did not modify antibody responses (Th-2 response). The dominant biological effect of CSE blockade was a repression of the IL-12 p40, T-Bet and IL-1β transcripts inside the graft paralleled with a decrease, at the protein level, of IL-12 and IFN-γ. In parallel, we found that tolerance induced by costimulation blockade or immunosuppression after heart and kidney allotransplantation in the LEW.1W to LEW.1A rat model was associated with a two to five fold repression of intragraft CSE, as well as of several other enzymes of the trans-sulfuration pathway. Monocytes and Dendritic cells treated by PPG or by the reversible CSE inhibitor, β-cyano alanine, as well as by siRNA specific for CSE, dose-dependently and differentially regulated production of IL-12 cytokine. The effect was independent of NFkB or H~2~S production, but could be assigned to a modulation of intracellular cysteine content.

Conclusion
==========

Our results identify CSE as a novel factor that plays a critical role in IL-12 production by monocytes and DCs by modulating intracellular cysteine levels, which in turn controls Th-1 type immune responses.
